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Abstract
Background: Although in developing countries the burden of morbidity and mortality due to infectious diseases has often
overshadowed that due to chronic non-communicable diseases (NCDs), there is evidence now of a shift of attention to NCDs.
Discussion: Decreasing the chronic NCD burden requires a two-pronged approach: implementation of the multisectoral
policies aimed at decreasing population-level risks for NCDs, and effective and affordable delivery of primary care interventions
for patients with chronic NCDs. The primary care response to common NCDs is often unstructured and inadequate. We
therefore propose a programmatic, standardized approach to the delivery of primary care interventions for patients with NCDs,
with a focus on hypertension, diabetes mellitus, chronic airflow obstruction, and obesity. The benefits of this approach will
extend to patients with related conditions, e.g. those with chronic kidney disease caused by hypertension or diabetes. This
framework for a "public health approach" is informed by experience of scaling up interventions for chronic infectious diseases
(tuberculosis and HIV). The lessons learned from progress in rolling out these interventions include the importance of gaining
political commitment, developing a robust strategy, delivering standardised interventions, and ensuring rigorous monitoring and
evaluation of progress towards defined targets.
The goal of the framework is to reduce the burden of morbidity, disability and premature mortality related to NCDs through
a primary care strategy which has three elements: 1) identify and address modifiable risk factors, 2) screen for common NCDs
and 3) and diagnose, treat and follow-up patients with common NCDs using standard protocols. The proposed framework for
NCDs borrows the same elements as those developed for tuberculosis control, comprising a goal, strategy and targets for NCD
control, a package of interventions for quality care, key operations for national implementation of these interventions (political
commitment, case-finding among people attending primary care services, standardised diagnostic and treatment protocols,
regular drug supply, and systematic monitoring and evaluation), and indicators to measure progress towards increasing the
impact of primary care interventions on chronic NCDs. The framework needs evaluation, then adaptation in different settings.
Summary: A framework for a programmatic "public health approach" has the potential to improve on the current unstructured
approach to primary care of people with chronic NCDs. Research to establish the cost, value and feasibility of implementing the
framework will pave the way for international support to extend the benefit of this approach to the millions of people worldwide
with chronic NCDs.
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Background
The international health focus in the past two decades has
been on the problem of infectious diseases, with non-
communicable diseases (NCDs) given a low priority at
global level [1]. However recognition is increasing of the
double burden in developing countries of chronic com-
municable diseases (e.g. tuberculosis and HIV) and
chronic NCDs [2], based on emerging country-level evi-
dence [3]. Attention to chronic NCDs is now increasing
for several reasons: 1) they have a huge negative economic
impact [4] and represent a significant impediment to
human development [5]; 2) the effects of globalisation are
likely to have a particular impact on chronic NCDs,
including diabetes, hypertension, smoking-related condi-
tions and obesity; and 3) recent progress in mobilising
funds and improving the response to infectious diseases
(especially HIV/AIDS, tuberculosis and malaria) has ena-
bled a shift to a broader global health outlook.
The main international focus is on those chronic NCDs
(diabetes, hypertension, chronic airflow obstruction and
obesity) which share the following characteristics: 1) they
are becoming more common as a consequence of the
effects of globalisation; 2) enough preliminary data on
these conditions are available to justify the conclusion
that they are contributing to epidemiological transition (a
double burden of communicable diseases and non-com-
municable diseases) in a wide range of low- and middle-
income countries; 3) they share common risk factors
which are potentially amenable to behavioural modifica-
tion (tobacco use, unhealthy diets, physical inactivity, and
harmful use of alcohol) [6]; 4) they can be detected using
simple tests available (or potentially readily available) in
primary care settings in low-income countries: hyperten-
sion (sphygmomanometer), chronic airflow obstruction
(peak expiratory flow meter), diabetes (urine or blood
glucose) and obesity (weight and height); 5) they can be
managed in typical primary care settings in middle- and
low-income countries; 6) the benefits of prevention and
care extend to related conditions of public health impor-
tance, e.g. chronic kidney disease (often caused by hyper-
tension or diabetes); and 7) they are the focus of World
Health Organization efforts, such as the launch of the new
global initiative in July 2009, to try to ensure that NCDs
are urgently accorded greater priority in the health and
development policies of poor nations and on global aid
agendas [8]. If the framework for the selected chronic
NCDs proves useful, it may pave the way for structured
approaches to the prevention and management of other
chronic NCDs such as chronic kidney disease, chronic
liver disease and chronic organic brain syndromes (e.g.
the dementias).
Recent estimates and projections have revealed the extent
of the global burden of chronic NCDs. The World Health
Organization (WHO) predicts a 17% increase in global
NCD deaths over the next decade, with the greatest
increase in Africa (27%) [8]. In 2007, it was estimated that
there were 246 million people living with diabetes melli-
tus, 6 million new cases and 3.8 million deaths, with 70%
of these patients living in the developing world [9]. In
2000, there were an estimated 972 million people with
hypertension, 65% of whom lived in the developing
world, with the number predicted to grow to 1.5 billion
by 2025 [10]. Chronic obstructive pulmonary disease sim-
ilarly affects large numbers of people with an estimated
300 million living with asthma [11] and 61 million living
with chronic airflow obstruction [12], with three-quarters
of the patients living in Asia and Africa. The chronic NCD
burden is likely to increase further as scaled-up pro-
grammes of antiretroviral treatment (ART) of HIV-
infected people lead to reduced HIV/AIDS mortality and
to possible metabolic side-effects resulting from life-long
ART [13].
A worldwide goal for the prevention and control of NCDs
has been proposed to complement the Millennium Devel-
opment Goals, with the accompanying target of an addi-
tional 2% per year reduction in death rates attributable to
the main chronic diseases (heart disease, stroke, cancer,
diabetes, and chronic respiratory diseases) [14]. WHO has
developed a global strategy and action plan for the pre-
vention and control of NCDs [8]. This comprehensive
multisectoral approach covers the development of
national policy frameworks, establishment of pro-
grammes, building of capacity for an effective national
response, monitoring and evaluation at different levels,
and promotion of research, but does not include a frame-
work for action to improve the primary care response to
chronic NCDs. Although primary care is the health service
entry point for the vast majority of people with NCDs and
therefore plays a key role in the delivery of prevention and
care interventions [15], the primary care response to com-
mon NCDs is often unstructured and inadequate. There is
an urgent need for an effective and affordable framework
for use and adaptation by countries to improve the deliv-
ery of interventions for patients with chronic NCDs by
primary care providers, including those in the government
services (whether Ministry of Health services or not, e.g.,
social-security schemes, prisons, military) and non-gov-
ernment services (e.g., non-governmental organisations,
and private practitioners). In practice in many developing
countries, secondary and tertiary care institutions often
also provide primary care.
Chronic NCDs in developing countries have often been
neglected despite their huge burden of morbidity and
mortality. Efforts to decrease population-level risks for
NCDs need to be accompanied by action to improve the
delivery of primary care interventions for people withBMC Public Health 2009, 9:355 http://www.biomedcentral.com/1471-2458/9/355
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NCDs. We propose a framework for action to ensure an
effective and affordable primary care response to chronic
NCDs.
Discussion
Rationale for a global framework for action to improve the 
primary care response to chronic NCDs
Health care delivery systems in developing countries are
generally less well oriented towards dealing with chronic
NCDs than with infectious diseases. The approach is often
unstructured, lacks systematic follow-up and monitoring
of chronic clinical care, and provides little information
about morbidity or mortality. Moreover, access to essen-
tial supplies is often limited and comes at a relatively high
cost [16]. This situation is common in developing coun-
tries in sub-Saharan Africa [17] and other regions. A lack
of quality health information is one of the main obstacles
in developing national strategies for an effective response
to NCDs [18]. There is a need to document the baseline
and future trends in burden of NCDs which may be exac-
erbated by the effects of globalisation, including global
climate change. This information on NCDs is needed for
purposes of planning local, national and international
responses to changing patterns of disease burden, and
monitoring the impact of these responses on disease bur-
den.
Suggested ways to improve the primary health care
response to chronic NCDs include: a) the integrated man-
agement of chronic NCDs with that of chronic communi-
cable diseases [19], e.g. as demonstrated in Cambodia
with HIV, diabetes and hypertension [20]; b) the develop-
ment of chronic care services that cut across conventional
categories of infectious diseases and NCDs [21]; and c)
the incorporation of indicators of programme perform-
ance and access to services [22]. The standard approach to
diagnosis and treatment, and evaluation and reporting of
treatment outcomes, which has been a cornerstone of the
international strategy to control tuberculosis [23], can be
adapted for NCDs - simple systems can be established for
monitoring and evaluation of outcomes of patients and of
programme performance (through quarterly and cumula-
tive cohort analyses of the numbers of cases registered and
their outcomes), as has been shown with the reporting of
ART scale-up in Malawi [24]. The importance of this
approach to monitoring and evaluation is reflected by
Objective 6 of the WHO Action Plan "to monitor non-
communicable diseases and their determinants and eval-
uate progress..." [8]. The establishment of multidiscipli-
nary chronic disease clinics using standardised
approaches to patient management could bring efficiency
gains, especially in providing continuity of care [25] (an
important element of quality care), long-term adherence
support [26] and social support, and may help to decrease
the stigma often associated with HIV and tuberculosis.
Improvements on the current situation are likely with a
programmatic, standardized approach to the delivery of
primary care interventions for patients with NCDs, incor-
porating the above suggestions. The framework for this
"public health approach" is designed to improve the man-
agement of the vast majority of people with NCDs who
can be managed satisfactorily in primary care. The frame-
work also incorporates referral of people with NCDs
needing more complex management in secondary or ter-
tiary care. The proposed framework is informed by experi-
ence of scaling up interventions for chronic infectious
diseases [24]. The lessons learned from progress in rolling
out interventions for the diagnosis and treatment of tuber-
culosis [27] and HIV infection [28] include the impor-
tance of gaining political commitment, developing a
robust strategy, delivering standardised interventions,
ensuring rigorous monitoring and evaluation of progress
towards defined targets, and setting ambitious targets
which serve as an aspiration for rallying stakeholders in
their efforts and helping to increase resources for the glo-
bal response. The proposed framework for NCDs borrows
the same elements as those developed for tuberculosis
control [29], comprising a goal, strategy and targets for
NCD control, a package of interventions for quality care,
key operations for national implementation of these
interventions, and indicators to measure progress towards
increasing the impact of primary care interventions on
chronic NCDs. The generic global framework can be
adapted at national level and validated for particular set-
tings, with operational evaluation of feasibility, effective-
ness, cost and cost-effectiveness.
A proposed global framework for the primary care 
response to chronic NCDs
Goal
To reduce the burden of morbidity, disability and prema-
ture mortality related to NCDs.
Strategy for the primary care contribution to NCD control
Among all those seen in primary care, 1) identify and
address modifiable risk factors, 2) screen for common
NCDs and 3) diagnose, treat, follow-up and when neces-
sary refer patients with common NCDs using standard
protocols.
In many countries, a substantial proportion of the popu-
lation accesses the primary care system each year. Primary
care is an important site for chronic disease prevention as
well as care, and those accessing primary care represent a
target group for delivery of prevention and care interven-
tions. To complement the multisectoral measures aimed
at primary prevention of NCDs, everyone seen in primary
care should be assessed for common risk factors such as
smoking, alcohol and obesity, and counseled on lifestyle
modification. Low-cost, rapid and reliable means ofBMC Public Health 2009, 9:355 http://www.biomedcentral.com/1471-2458/9/355
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screening are available for common NCDs, e.g. hyperten-
sion (automatic sphygmomanometer), chronic airflow
obstruction (peak expiratory flow meter), diabetes (urine
or finger-prick dipsticks) and obesity (weighing scales and
height measuring rod to enable calculation of body mass
index). A structured approach to delivering quality care
for patients with common NCDs involves the use of sim-
ple standard protocols for diagnosis, treatment, follow-up
and referral.
Targets
1. To assess 90% of patients presenting to primary health
care facilities for three common modifiable risk factors for
NCD - namely, cigarette smoking, alcohol and obesity -
and to address those risk factors when present.
2. To screen 90% of all patients presenting to primary
health care facilities at least once each year for common
NCDs using simple tests for hypertension (automatic
sphygmomanometer), chronic airflow obstruction (peak
expiratory flow meter), diabetes (urine or blood glucose,
with proteinuria also detectable by dipstick testing of the
urine) and obesity (weight and height).
3. To ensure that 90% of patients diagnosed with hyper-
tension, diabetes, obesity, and chronic airflow obstruc-
tion are managed and continue within life-long structured
and monitored primary care.
Package of interventions for quality care
1. Political commitment
Chronic diseases require a (chronic) sustained response
and political commitment. Sustained government com-
mitment to comprehensive health system strengthening
should include commitment to addressing the problem of
NCDs. The government has several key roles, including
leadership, stewardship, resource mobilisation and allo-
cation, policy development and implementation, and
health workforce development.
2. Case-finding among people attending primary care services
This is a central part of the strategy for the primary care
contribution to NCD control. Those accessing primary
care represent a target group for delivery of prevention
and care interventions. The linked delivery of prevention
and care interventions is important: providing care with-
out prevention and vice versa represent missed opportuni-
ties.
3. Standardised diagnostic and treatment protocols
The use of simple standard protocols for diagnosis, treat-
ment, follow-up and, when necessary, referral of patients
with common NCDs can ensure a structured approach to
delivering quality care. Generic protocols for standard
case management, using simple and inexpensive tools
and drugs, should be adapted at national level and vali-
dated for the particular circumstances in particular set-
tings.
4. Regular drug supply
A regular supply of essential drugs is necessary for the
quality care of people with NCDs, since an individual
patient's clinical course will deteriorate if treatment is
interrupted.
5. Systematic monitoring and evaluation
Quarterly and cumulative cohort analyses of the numbers
of cases registered and their outcomes are the vital signs of
NCD management. Key indicators are: the numbers of
patients registered and retained on treatment, and the pri-
mary outcomes of alive, dead, stopped treatment, lost to
follow-up and transferred to another facility. The number
of new cases started on treatment in any given time period
represents the new incident cases, and provides a gauge of
access to treatment and case detection if the number of
expected cases is known or estimated. The cumulative
number of patients retained alive and on treatment repre-
sents the burden of disease, the data being essential for
proper planning of logistics and accurate drug forecasting.
Cumulative numbers who have died, have been lost to
follow-up or who have stopped treatment provide a meas-
ure of programme performance.
Key operations for national implementation of these 
interventions
1. Political commitment
1.1 Establish an adequately staffed and funded NCDs and
health promotion unit within the Ministry of Health, with
guidance on evidence-based policy from a National Advi-
sory Committee. Health promotion includes community
sensitisation on NCDs.
1.2 Mobilise and coordinate the investment of funds in
strengthening the primary care system to enable delivery
of quality care for people with NCDs. Areas of investment
include human resources, health care infrastructure,
secure supply of materials for diagnosis and of drugs, and
record-keeping.
1.3 Develop and disseminate a manual for the strength-
ened primary care response to NCDs, to be used as a pol-
icy reference guide and training tool.
2. Case-finding among people attending primary care services
2.1 Train primary care staff to be able to deliver the strat-
egy for the primary care response to NCDs. Staff should
take the opportunity when people are seen in primary care
to: 1) identify and address modifiable risk factors, 2)
screen for common NCDs, and 3) diagnose, treat and fol-BMC Public Health 2009, 9:355 http://www.biomedcentral.com/1471-2458/9/355
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low-up patients with common NCDs using standard pro-
tocols.
2.2 Ensure the availability of the essential materials for
diagnosis, treatment and record-keeping which primary
care staff need to deliver the strategy.
3. Standardised diagnostic and treatment protocols
3.1 Develop or apply established simple standard proto-
cols for diagnosis, treatment, follow-up and, when neces-
sary, referral of patients with common NCDs which can
ensure a structured approach to delivering quality care.
3.2 Ensure the protocols are validated to reflect the
approach which is relevant to those NCDs which are com-
mon in a particular country, and updated to reflect chang-
ing circumstances.
4. Regular drug supply
4.1 Strengthen the national system of drug procurement
and delivery to ensure regular and reliable delivery of
essential drugs to primary care facilities.
4.2 Base the forecasting of drug requirements on the sys-
tematic registration of patients and recording and report-
ing of their outcomes.
4.3 Obtain access to quality-assured, affordable drugs
through manufacture of appropriate generic formulations
(suitable for storage under local conditions) and pooled
procurement mechanisms. The success of the drug supply
system established along these lines through the Global
Drug Facility for anti-tuberculosis drugs [30] is now being
extended to the supply of drugs for chronic respiratory
diseases through the Asthma Drug Facility and may be fur-
ther extended to drugs for other NCDs.
5. Systematic monitoring and evaluation
5.1 Ensure an efficient system for data collection, entry
and management, which enables assessment of clinical
progress of individual patients and a comprehensive
assessment of the burden of chronic NCDs and its
response to health system interventions.
5.2 Design and implement a patient-held record (e.g.
"health passport") which indicates the essential informa-
tion for chronic care - the key clinical findings, main diag-
noses, treatments, and appointments for review
(including referral) - to complement the recommended
record-keeping system for health facilities (as a fail-safe in
case the health facility system doesn't work and as an aide-
memoire for the patient).
5.3 Design and implement a user-friendly and reliable
record-keeping system for health facilities, which may be
entirely paper-based, paper-based with a computer-based
system for data aggregation and cohort reporting, or
entirely computer-based. Introduction of robust, easy-to-
use, touch screen computer systems in primary care facili-
ties could enable rapid and efficient record-keeping by
staff, and ready access to data for analysis.
5.4 Use strategic information (obtained from routine
recording and reporting) to guide improvement in the
quality of patient care at the point of care delivery (as is
the case, for example, for the recommended system of
routine recording and reporting of patients' response to
anti-tuberculosis treatment) [31].
Indicators to measure progress towards increased impact
of primary care interventions on chronic NCDs
Proposed indicators that could be used at country level to
measure progress in NCD management include:
1) a national NCD policy framework that is available in
the Ministry of Health;
2) the number of administrative areas in the country that
regularly report on the incidence and prevalence of NCD
cases reported in primary care;
3) the number of new incident cases reported in primary
care over defined time periods;
4) the number of patients alive and on standardised
nationally approved therapy (i.e. prevalence of those
receiving care) at defined moments in time.
Next steps
The proposed framework needs to be evaluated and
implementation priorities determined in different settings
according to the prevailing NCD epidemiology. A pro-
gramme of health system research is urgently needed to
establish the feasibility of implementation, and its cost,
cost-effectiveness and acceptability [32]. Such research is
responsive to the needs of developing countries [33], and
is in line with that proposed by the representatives of
health policy and research agencies who developed the
"Grand challenges in chronic non-communicable dis-
eases" [34]. Research on local implementation, e.g. at dis-
trict level, is necessary to support effective national scale-
up [35]. The approach in a particular setting depends on
assessment of the local health structure, e.g. regarding the
role of district hospitals in supporting local primary care
facilities, and of human resources. A research approach of
"learning by doing" will help to address the many practi-
cal issues concerning the required human and infrastruc-
ture resources, especially in handling increased NCD case-
finding, and the acceptability and logistics of providingBMC Public Health 2009, 9:355 http://www.biomedcentral.com/1471-2458/9/355
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integrated care, e.g. clinics for chronic NCDs and chronic
infectious diseases. In addition to the information gener-
ated by the proposed framework on NCDs among people
accessing primary care, NCD epidemiological surveillance
is needed to establish the population-level burden of
NCDs and assess the proportion of cases detected and
managed by the health system.
The Director-General of WHO has recently highlighted
the importance of strengthened health systems based on
primary care as "the route to greater efficiency and fairness
in health care and greater security in the health sector and
beyond" [36]. This vision of primary care must encom-
pass improved delivery of interventions for the many peo-
ple with NCDs seen in primary care. Providing affordable
and effective primary care to the often large and increasing
numbers of people with NCDs in developing countries
will be an immense challenge. The scale of this challenge
should be taken not as discouragement, but as a reason for
action, in mobilising the wide range of stakeholders
involved, finding the resources, and taking the necessary
steps to meet the challenge. Implementation of the frame-
work should capitalise on synergies with other disease
control efforts in addressing the necessary human and
infrastructure resources required to provide quality care,
as part of strengthening health systems. Set against the
cost of action, the cost of inaction on NCDs is measured
in terms of the human toll of illness, disability and death,
and the economic toll of lost productivity and develop-
ment potential.
Summary
• In many developing countries the current approach
to delivery of primary care interventions for people
with chronic NCDs is often unstructured and inade-
quate.
￿ Informed by lessons learned from progress in scaling
up interventions for tuberculosis and HIV, a frame-
work for a "public health approach" has the potential
to provide an effective and affordable solution to this
neglected problem.
￿ The elements of the proposed framework for NCDs
comprise a goal, strategy and targets, a package of
interventions for quality care, key operations for
national implementation of these interventions, and
indicators to measure progress towards increasing the
impact of primary care interventions on chronic
NCDs.
￿ If implementation of the proposed framework is
found to be feasible, effective and cost-effective, inter-
national support can be mobilised to extend the ben-
efit of this approach to the millions of people
worldwide with chronic NCDs.
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